Global Economic Impact of MS

It is estimated that the average financial cost of MS in high income countries is more than $US 1.2 million per person. Loss of employment, or early retirement, is considered the single largest cost factor contributing to this financial cost.

Read the rest »

Could Early Symptoms of MS Be Stratified to Give Better Targeted Multiple Sclerosis Treatments?

If we knew early on what the disease course for Multiple Sclerosis would be then we could better target the medication in each individual case.

Read the rest »

Increased Risk of Disability Progression in MS with Vascular Co-morbidity

Hello again. Thanls for calling back. REMEMBER to share any post you like. Just click share and you can choose where to share it OR if you have a twitter account just “Tweet This” at the end of the post.. Thanks for visiting! —————————–> Well that’s a  bit of a scary phrase. Introduction Vascular co-morbidity [...]

Read the rest »

Venous blood flow and iron deposition in multiple sclerosis

It has been recently shown that MS is significantly associated with a condition defined as chronic cerebrospinal venous insufficiency (CCSVI). In CCSVI, put simply, there is a narrowing of the vessels draining blood away from the brain.Blocked venous blood outflow causes a high rate of cerebral venous reflux in MS patients.

Read the rest »

The Next Challenge to Understanding Multiple Sclerosis

We do not know how so many different infections could have a role in MS and how they might interact with genetic risk factors but, it is also important to try to understand how non-infectious risk factors, such as sunlight, may interact with genetic risk factors.

Read the rest »

Pet Therapy and Assistance

Many people believe that pets are important to a healthy life and even claim that their animals have human-like abilities, such as sensing the feelings of their owners and reacting accordingly. In the past few years, studies have been conducted to understand whether there is therapeutic value in contact between humans and animals. In some [...]

Read the rest »

Promising psychosocial treatments for pain in MS

This article is adapted from the article published by MSIF of the same name. For some people with MS, medicines can provide complete relief from pain,but many pain sufferers do not achieve adequate pain relief by pharmacological means. Fortunately, a number of non-pharmacological approaches can be used that have been proven to be effective in [...]

Read the rest »

Pain in Multiple Sclerosis part 3 – Secondary pain

Pain is defined as an “unpleasant sensory experience associated with actual or potential tissue damage or described in terms of such damage”. But data available in research literature on pain management is sadly lacking so symptom management in MS represents a primary focus for health care professionals. A lot of the pain in MS is [...]

Read the rest »

Pain in multiple sclerosis part 2 – Neurogenic pain

Half of all people with MS will experience pain from time to time because of the condition. Fortunately for most, the pain is usually mild. But, for a small number, pain is a more severe and ongoing symptom that may need specialised assessment and treatment. In this article I will address pain which arises from [...]

Read the rest »

The Next Challenge to Understanding Multiple Sclerosis

Introduction As we know Multiple sclerosis is a common neurological disease that affects 1 in 1,000 people, most commonly young women, although men too to a lesser extent. The typical disease progress includes attacks and remissions with slowly progressing disability. Current therapies can prevent the appearance of new events, but they have much less effect [...]

Read the rest »